16th World ADC (WADC 2025)

As an already eventful conference season continues, Nordic Bioscience is excited to participate in the 16th Annual World ADC USA, taking place November 3-6, 2025, in San Diego, CA.

This leading event in antibody-drug conjugate development gathers industry innovators to explore technologies that improve targeting, safety, and efficacy. Nordic Bioscience will be onsite with a booth, sharing how our expertise in tumor fibrosis and extracellular matrix remodeling can contribute to the next generation of ADCs.

Understanding and measuring fibrotic remodeling in the tumor microenvironment is critical for optimizing ADC delivery and therapeutic response. Our biomarker platforms provide insights into stromal barriers, including CAF activity and collagen dynamics, which can influence payload penetration and drug efficacy.

Visit us at our booth to learn how integrating fibrosis biomarkers into ADC programs can drive smarter design, patient selection, and clinical trial strategies.